{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T21:51:20Z","timestamp":1777067480633,"version":"3.51.4"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Current approved COVID-19 vaccines, notably mRNA and adenoviral vectored technologies, still fail to fully protect against infection and transmission of various SARS-CoV-2 variants. The mucosal immunity at the upper respiratory tract represents the first line of defense against respiratory viruses such as SARS-CoV-2 and is thus critical to develop vaccine blocking human-to-human transmission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We measured systemic and mucosal Immunoglobulin A (IgA) response in serum and saliva from 133 healthcare workers from Percy teaching military hospital following a mild infection (SARS-CoV-2 Wuhan strain, n=58) or not infected (n=75), and after SARS-CoV-2 vaccination (Vaxzevria\u00ae\/Astrazeneca and\/or Comirnaty\u00ae\/Pfizer).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>While serum anti-SARS-CoV-2 Spike IgA response lasted up to 16 months post-infection, IgA response in saliva had mostly fallen to baseline level at 6 months post-infection. Vaccination could reactivate the mucosal response generated by prior infection, but failed to induce a significant mucosal IgA response by itself. Early post-COVID-19 serum anti-Spike-NTD IgA titer correlated with seroneutralization titers. Interestingly, its saliva counterpart positively correlated with persistent smell and taste disorders more than one year after mild COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>As breakthrough infections have been correlated with IgA levels, other vaccine platforms inducing a better mucosal immunity are needed to control COVID-19 infection in the future. Our results encourage further studies to explore the prognosis potential of anti-Spike-NTD IgA in saliva at predicting persistent smell and taste disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2023.1140714","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:52:06Z","timestamp":1678236726000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders"],"prefix":"10.3389","volume":"14","author":[{"given":"Jessica","family":"Denis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabelle","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Cheutin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Ferrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hawa","family":"Timera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Jarjaval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Hejl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Billon-Denis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Percy ImmunoCovid group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Ricard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Nicolas","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Trignol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Mura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026239","article-title":"Incidence of influenza in healthy adults and healthcare workers: A systematic review and meta-analysis","volume":"6","author":"Kuster","year":"2011","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100933","DOI":"10.1016\/j.cegh.2021.100933","article-title":"Exposure risk and COVID-19 infection among frontline health-care workers: A single tertiary care centre experience","volume":"13","author":"Vargese","year":"2022","journal-title":"Clin Epidemiol Glob Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jinf.2021.06.023","article-title":"Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination","volume":"84","author":"Hsu","year":"2022","journal-title":"J Infect"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmilitary-2022-002082","article-title":"Vaccine efficacy against the SARS-CoV-2 delta variant during a COVID-19 outbreak aboard a military ship","volume":"29","author":"Maugey","year":"2022","journal-title":"BMJ Mil Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3390\/vaccines10091555","article-title":"Role and limits of COVID-19 vaccines in the delicate transition from pandemic mitigation to endemic control","volume":"10","author":"Mura","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00822-w","article-title":"SARS-CoV-2 viral load and shedding kinetics","volume":"21","author":"Puhach","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn6868","article-title":"Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model","volume":"14","author":"Langel","year":"2022","journal-title":"Sci Transl Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1038\/s41467-021-27063-4","article-title":"Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization","volume":"12","author":"Lapuente","year":"2021","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo2523","article-title":"Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses","volume":"378","author":"Mao","year":"2022","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-022-00569-w","article-title":"Role of the humoral immune response during COVID-19: guilty or not guilty","volume":"15","author":"Yaugel-Novoa","year":"2022","journal-title":"Mucosal Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01028-7","article-title":"Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection","volume":"22","author":"Smith","year":"2021","journal-title":"Nat Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3402\/jom.v5i0.20401","article-title":"Secretory immunity with special reference to the oral cavity","volume":"5","author":"Brandtzaeg","year":"2013","journal-title":"J Oral Microbiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6619","article-title":"Natural polyreactive IgA antibodies coat the intestinal microbiota","volume":"358","author":"Bunker","year":"2017","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41591-021-01296-8","article-title":"SARS-CoV-2 infection of the oral cavity and saliva","volume":"27","author":"Huang","year":"2021","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"eabe5511","DOI":"10.1126\/sciimmunol.abe5511","article-title":"Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients","volume":"5","author":"Isho","year":"2020","journal-title":"Sci Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41385-022-00511-0","article-title":"Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection","volume":"15","author":"Sheikh-Mohamed","year":"2022","journal-title":"Mucosal Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e2238804","DOI":"10.1001\/jamanetworkopen.2022.38804","article-title":"Prevalence and correlates of long COVID symptoms among US adults","volume":"5","author":"Perlis","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.3390\/v14112367","article-title":"Infection with SARS-CoV-2 variants is associated with different long COVID phenotypes","volume":"14","author":"Spinicci","year":"2022","journal-title":"Viruses"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2022.11.003","article-title":"Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms","volume":"46","author":"Butowt","year":"2022","journal-title":"Trends Neurosci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.30637","article-title":"Sociodemographic characteristics and comorbidities of patients with long COVID and persistent olfactory dysfunction","volume":"5","author":"Mendes Paranhos","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B21","doi-asserted-by":"publisher","first-page":"103607","DOI":"10.1016\/j.amjoto.2022.103607","article-title":"Recovery from covid-19 smell loss: Two-years of follow up","volume":"43","author":"McWilliams","year":"2022","journal-title":"Am J Otolaryngol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1101\/2022.08.09.22278592","article-title":"Distinguishing features of long COVID identified through immune profiling","author":"Klein","year":"2022","journal-title":"medRxiv"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.03.016","article-title":"Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients","volume":"28","author":"Peghin","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14994","article-title":"Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction","volume":"28","author":"Saussez","year":"2021","journal-title":"Eur J Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1038\/s41467-022-32389-8","article-title":"SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals","volume":"13","author":"Sano","year":"2022","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2209651","article-title":"Anti-spike mucosal IgA protection against SARS-CoV-2 omicron infection","volume":"387","author":"Havervall","year":"2022","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.611337","article-title":"Mucosal immunity in COVID-19: A neglected but critical aspect of SARS-CoV-2 infection","volume":"11","author":"Russell","year":"2020","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1006040","article-title":"Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic review","volume":"13","author":"Guerra","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218456","article-title":"High similarity of IgG antibody profiles in blood and saliva opens opportunities for saliva based serology","volume":"14","author":"Hettegger","year":"2019","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.identj.2022.09.005","article-title":"BNT162b2 mRNA vaccine-induced immune response in oral fluids and serum","author":"Seneviratne","year":"2022","journal-title":"Int Dent J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/dj9040043","article-title":"The impact of oral health on respiratory viral infection","volume":"9","author":"Tada","year":"2021","journal-title":"Dent J (Basel)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263419","article-title":"Saliva as a useful tool for evaluating upper mucosal antibody response to influenza","volume":"17","author":"Tsunetsugu-Yokota","year":"2022","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00016-T","article-title":"Human immune responses to influenza virus vaccines administered by systemic or mucosal routes","volume":"13","author":"Moldoveanu","year":"1995","journal-title":"Vaccine."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267102","article-title":"Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients","volume":"17","author":"Chansaenroj","year":"2022","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708184","article-title":"Dynamic characteristic analysis of antibodies in patients with COVID-19: A 13-month study","volume":"12","author":"Shi","year":"2021","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"eabd2223","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci Transl Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6866","DOI":"10.1038\/s41467-022-34633-7","article-title":"A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the n-terminal domain","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","volume":"184","author":"McCallum","year":"2021","journal-title":"Cell."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.610300","article-title":"Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases","volume":"11","author":"Carsetti","year":"2020","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jaci.2020.10.040","article-title":"Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19","volume":"147","author":"Cervia","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf1555","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2021","journal-title":"Sci Transl Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41467-021-20973-3","article-title":"Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-ab to evaluate endemic coronavirus cross-reactivity","volume":"12","author":"Becker","year":"2021","journal-title":"Nat Commun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"110336","DOI":"10.1016\/j.celrep.2022.110336","article-title":"SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people","volume":"38","author":"Narowski","year":"2022","journal-title":"Cell Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.cell.2021.02.010","article-title":"Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection","volume":"184","author":"Anderson","year":"2021","journal-title":"Cell."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1803","article-title":"Absence of severe acute respiratory syndrome coronavirus 2 neutralizing activity in prepandemic sera from individuals with recent seasonal coronavirus infection","volume":"73","author":"Poston","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"103700","DOI":"10.1016\/j.ebiom.2021.103700","article-title":"Relative ratios of human seasonal coronavirus antibodies predict the efficiency of cross-neutralization of SARS-CoV-2 spike binding to ACE2","volume":"74","author":"Galipeau","year":"2021","journal-title":"EBioMedicine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.chom.2021.12.005","article-title":"Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response","volume":"30","author":"Lin","year":"2022","journal-title":"Cell Host Microbe"},{"key":"B49","doi-asserted-by":"publisher","first-page":"110169","DOI":"10.1016\/j.celrep.2021.110169","article-title":"Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses","volume":"37","author":"Wratil","year":"2021","journal-title":"Cell Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.chom.2022.07.012","article-title":"Immunological memory to common cold coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemic","volume":"30","author":"Yu","year":"2022","journal-title":"Cell Host Microbe"},{"key":"B51","doi-asserted-by":"publisher","first-page":"103788","DOI":"10.1016\/j.ebiom.2021.103788","article-title":"Mucosal immune response in BNT162b2 COVID-19 vaccine recipients","volume":"75","author":"Azzi","year":"2022","journal-title":"EBioMedicine."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17186","article-title":"Kinetics and persistence of cellular and humoral immune responses to SARS-CoV-2 vaccine in healthcare workers with or without prior COVID-19","volume":"26","author":"Chivu-Economescu","year":"2022","journal-title":"J Cell Mol Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3892\/mmr.2021.12217","article-title":"COVID19 vaccination and IgG and IgA antibody dynamics in healthcare workers","volume":"24","author":"Zurac","year":"2021","journal-title":"Mol Med Rep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.820250","article-title":"Natural SARS-CoV-2 infection affects neutralizing activity in saliva of vaccinees","volume":"13","author":"Garziano","year":"2022","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/imr.12900","article-title":"Imprinting, immunodominance, and other impediments to generating broad influenza immunity","volume":"296","author":"Knight","year":"2020","journal-title":"Immunol Rev"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e2026752118","DOI":"10.1073\/pnas.2026752118","article-title":"Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates","volume":"118","author":"McCarthy","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/j.jinf.2020.06.054","article-title":"Persisting olfactory dysfunction in patients after recovering from COVID-19","volume":"81","author":"Otte","year":"2020","journal-title":"J Infect"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf8396","article-title":"COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters","volume":"13","author":"de Melo","year":"2021","journal-title":"Sci Transl Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10153305","article-title":"One year after mild COVID-19: The majority of patients maintain specific immunity, but one in four still suffer from long-term symptoms","volume":"10","author":"Rank","year":"2021","journal-title":"J Clin Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/life12101556","article-title":"Two-year follow-up on chemosensory dysfunction and adaptive immune response after infection with SARS-CoV-2 in a cohort of 44 healthcare workers","volume":"12","author":"Schambeck","year":"2022","journal-title":"Life (Basel)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1473-3099(20)30200-0","article-title":"Clinical and virological data of the first cases of COVID-19 in Europe: a case series","volume":"20","author":"Lescure","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1140714\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:52:08Z","timestamp":1678236728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1140714\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2023.1140714"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1140714","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.01.13.23284341","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]},"article-number":"1140714"}}